Professional Documents
Culture Documents
Dieter Mayer, Hoechst Aktiengesellschaft, Frankfurt / Main, Federal Republic of Germany (Chap. 8)
2. Production
The diphenyl bases Benzidine have aroused Benzidine and the other diphenyl bases are pro-
interest as cross-linking agents, e.g., in duced in three separate processing stages:
polyurethane plastics [10], in which they can
1) Reduction of nitro groups to form hydrazo
noticeably increase the temperature stability
compounds
[11]. The diphenyl radical has a chain-stiffening
2) Benzidine rearrangement
effect in polyamides [12]. The ability of the
3) Isolation of the bases
diphenyl bases to react with numerous cations,
anions, and organic substances, such as oxidiz-
ing agents and blood, is utilized for analytical
and diagnostic purposes. 2.1. Reduction
The economic importance of the diphenyl
bases is apparent from the fact that world pro- The alkaline reduction of nitrobenzene to hy-
duction in 1983 was about 15 kt. The major pro- drazobenzene can be represented by the simple
equation
sodium hydroxide in the molar ratio 1 : 2 : 4 at The catholyte consists of a vigorously stirred
a temperature of 100 – 120 ◦ C. emulsion of the nitro compound in 8 – 10 %
The process can be used for the reduction of sodium hydroxide solution. Ethanol and toluene
nitrobenzene to hydrazobenzene but less often can be used as diluents. Depending on the geom-
for its substitution products, especially because etry of the cell, solvents with high specific grav-
it is difficult to separate the hydrazo compound ities (chlorinated benzene, chlorinated toluene,
from the ferruginous mud. A yield of 88 – 92 % or chlorinated naphthalene) are used to keep the
has been reported for the reduction of nitroben- cathode liquid away from the anode compart-
zene to hydrazobenzene using ferrosilicon (15 % ment above it. Cement or special ceramic com-
Si) [14]. pounds are used to make the diaphragms. The
anolyte, consisting of 10 % sodium hydroxide
Reduction with Sodium Amalgam. solution, contains the lead or iron anode, which
Sodium amalgam at 70 – 100 ◦ C in an upright, has a PbO2 coating or, for preparative purposes,
cylindrical nickel reactor is brought into con- may also be nickel-plated.
tact with nitrobenzene emulsified in water or Electrochemical reduction is carried out at
sodium hydroxide. The process is carried out in temperatures of 65 – 90 ◦ C, current densities of
batches to produce azobenzene. The reduction about 20 A/dm2 and voltages of 4 – 10 V. Elec-
conditions can be varied by adding solvent (sol- trochemical reduction is technically satisfactory
vent naphtha), changing the concentration of and may also be cheaper than zinc dust reduc-
the sodium hydroxide solution or the amalgam, tion if it is interrupted when only about 50 %
or by adding decomposition catalysts (graphite, of the starting material has reached the hy-
activated charcoal). drazo stage. After rearrangement and separa-
Nevertheless, in the further reduction from tion of the diphenyl base salts, the azo compo-
the azo to the hydrazo stage, some overreduc- nents and the solvent are recovered for the next
tion to the monocyclic amine cannot be avoided. batch. Nitrobenzene, 2-chloronitrobenzene, 2,5-
The product formed contains up to 90 % azoben- dichloronitrobenzene, 2-nitrotoluene, and 2-
zene in addition to hydrazobenzene, aniline, and nitroanisol can be electrochemically reduced to
nitrobenzene. It is therefore isolated and further hydrazo compounds in yields of 70 – 90 % [14],
reduced to the hydrazo stage with zinc dust and [15].
sodium hydroxide solution. The amalgam reduc-
tion is used industrially only with unsubstituted Catalytic Reduction. Nitrobenzene can be
nitrobenzene. reduced to hydrazobenzene with hydrogen in the
presence of a palladium–carbon catalyst. Indus-
Electrolytic Reduction. The electrochemi- trially, reduction is carried out in dilute alcohol
cal reduction of nitro to hydrazo compounds is (ethyl or isopropyl alcohol) in the presence of
also carried out on a commercial scale. a base, such as 50 % sodium hydroxide solu-
tion. The reaction takes place in an autoclave
2 C6 H5 NO2 + 10 H+ + 10 e− −→ at 80 – 85 ◦ C and with a slightly elevated pres-
C6 H5 NH–NHC6 H5 + 4 H2 O sure. Overreduction is suppressed by the high
concentration of alkali. The yield can also be
Electrolytic cells, with cathodes, diaphragms, influenced by buffering the reaction medium,
and anodes positioned either side by side or e.g., by the addition of acetates, borates, or alka-
above each other, are used. nolamines. This reduction method also applies
The satisfactory functioning of electrolytic to 2-nitrotoluene and 2-nitroanisol.
reduction depends largely on the condition of the For preparative purposes, Raney nickel can
surface of the cathode. Sheet iron cathodes with be used at elevated temperatures and with mixed
a lead sponge are used. Overreduction is less catalysts. Instead of hydrogen, hydrazine hy-
likely to occur with a lead sponge than with shiny drate or sodium borohydride can be used with
lead surfaces. Even lead cathodes with spongy palladium – calcium carbonate, Raney nickel,
zinc have been used, but the spongy zinc was ruthenium – carbon, or copper ions as the cat-
partially used up by chemical reduction. Nickel alyst [14].
cathodes have also been described [14], [15].
4 Benzidine and Benzidine Derivatives
2.3. Isolation
Partial rearrangements yield o-semidine (2- The most important stage of the benzidine re-
aminodiphenylamine) (4) and p-semidine (4- arrangement is the formation of a hydrochlo-
aminodiphenylamine) (5). ric or sulfuric acid salt of the diphenyl base.
This is either isolated directly, e.g., by salting
out with sodium chloride or sodium sulfate, or
first converted into the free base. For this a di-
lute alkali, such as sodium hydroxide solution
or ammonia solution, should be used. The un-
The type and quantity of the rearrangement desirable byproducts, especially the monocyclic
products are largely dependent on the chemical amine and diphenyline, can be separated out rel-
constitution of the reactant and can only be in- atively easily because of the greater solubility of
fluenced to a limited extent by the reaction con- these bases and their salts. Finally, only the azo
ditions. The byproducts, mainly diphenyline (3), compound remains in the inert solvent after acid
are formed in quantities of up to 15 % and have extraction. It is returned to the reduction process
no commercial value. along with the solvent.
Benzidine and Benzidine Derivatives 5
b) closed systems, e.g., sealed containers or followed upon entering or leaving a regu-
piping systems lated area.
Special permission must be obtained 11) The storage, consumption, and use of food-
for access to closed systems; employ- stuffs, drinks, tobacco, cosmetics, and the
ees shall be required to wash themselves like are prohibited in regulated areas.
upon each exit from the regulated areas. 12) Decontamination procedures shall be es-
c) open vessel system operations are pro- tablished. Dry sweeping and dry mopping
hibited. are prohibited.
3) Upon completion of their work in isolated 13) The contents of the containers must be
or closed systems, employees must observe identified by suitable labels. The words
certain minimum regulations in terms of Cancer-Suspect Agent must be added, the
personal hygiene. minimum size print being stipulated.
4) When opening a system employees shall be 14) Any incidents must be reported to the rele-
required to wear clean, full-body protective vant authorities.
clothing, shoe covers, and gloves. Employ- 15) Deposits on machinery or parts of the build-
ees engaged in 3,3 -dichlorobenzidine (or ing are detected by a swipe test. Sodium
its salts) handling operations shall be re- hypochlorite solution must be used for de-
quired to use a half-face filter-type respira- contamination.
tor for dusts, mists, and fumes. In Great Britain the use (for research pur-
5) For the cleanup of leaks or spills and poses) of Prohibited Substances, such as ben-
maintenance or repair operations on con- zidine and its salts, is only possible if special
taminated systems, impervious garments, permission is obtained for work in completely
gloves, boots, and a hood with a continu- closed systems or if the benzidine, in the form
ous supply of air should be worn. of a hydrochloride, is always kept moist with
6) Prior to each exit from a regulated area, at least one part water to two parts benzidine
employees shall be required to remove and hydrochloride.
leave behind protective clothing and to Dichlorobenzidine, o-tolidine, o-dianisidine,
place used clothing and equipment in im- and their salts are designated Controlled sub-
pervious containers for purposes of decon- stances, and employees should be protected
tamination or disposal. from contamination by these substances. Work-
7) Employees shall be required to wash on ers are medically monitored and records kept
each exit from the regulated area and to [20].
shower after the last exit of the day. In the Federal Republic of Germany the im-
8) A daily roster of employees entering regu- portant diphenyl bases are included among the
lated areas shall be established and main- regulated dangerous working substances.
tained. Before taking up employment they
1) Benzidine and its salts are regarded as car-
must be informed of the carcinogenic haz-
cinogenic hazards in concentrations above
ard of 3,3 -dichlorobenzidine, of the possi-
0.01 % by weight in the working material.
bilities of contact with the product in their
2) 3,3 -Dichlorobenzidine is regarded as a car-
work, and of the medical surveillance pro-
cinogenic hazard in concentrations above
gram. They are subjected to an annual med-
0.1 % by weight in the working material.
ical examination.
3) o-Tolidine is considered harmful to health.
9) Signs bearing the following inscription
4) o-Dianisidine and its salts are considered
should be posted at the entry points of reg-
toxic.
ulated areas:
CANCER-SUSPECT AGENT When working with these substances, all the
AUTHORIZED PERSONNEL ONLY necessary measures relating to safety, industrial
10) More detailed warnings apply to contami- medicine, and occupational hygiene should be
nated areas. Additional signs should inform taken to protect employees from the effects of
employees of the procedures that must be these substances and to keep their health under
constant medical check. The air at the workplace
should be examined to monitor the benzidine
Benzidine and Benzidine Derivatives 7
and 3,3 -dichlorobenzidine contents. If benzi- can be slowly biodegraded. More than 90 % of
dine or 3,3 -dichlorobenzidine is marketed, the these two compounds can be eliminated in bi-
package must bear the words May cause cancer ological waste water treatment plants. Elimina-
[21]. tion takes place mainly by adsorption on sed-
Equipment in which benzidine or its salts may iments followed by slow biodegradation. Only
be present must be operated in such a way that a portion can be extracted again. This part de-
breakdowns are prevented and the harmful ef- clines as the adsorption process continues, be-
fects are kept to a minimum. All the necessary cause the 3,3 -dichlorobenzidine reacts with the
precautions are summarized in [22]. sediments [30].
In accordance with the technical regulations 3,3 -Dichlorobenzidine cannot be removed
for dangerous working substances, the presence quantitatively from waste water by hypochlo-
of an effect must always be assumed when han- rite solution because higher chlorinated ben-
dling benzidine. Here “effect” means the risk zidines are formed. Tetrazotization and con-
of damage to workers’ health. If the concentra- version into 3,3 -dichloro-4,4 -dihydroxybiphe-
tion of 3,3 -dichlorobenzidine in the air is below nyl are more suitable procedures; they reduce
0.1 mg/m3 at the workplace, it can be assumed the 3,3 - dichlorobenzidine content to less than
to have no effect on the worker [23]. 0.1 mg/kg [32]. Other appropriate waste water
In Belgium [24], Japan [25], and numerous purification processes are oxidation with perox-
other countries there are similar regulations for ide, adsorption on suspended adsorption agents,
handling benzidine and its derivatives [26]. Be- precipitation with iron(III) hydroxide, and com-
fore starting a job in which diphenyl bases can binations of these methods.
be formed or are used, it is high advisable to For decontamination of workrooms, build-
obtain exact details of the local regulations. ings, and machines, a hot solution of 5 wt%
tetrapotassium pyrophosphate and 10 wt%
sodium ethyl hexyl sulfate is sprayed on with a
5. Environmental Protection hydraulic jet cleaner in the ratio 1 : 10 with water
under pressure, so that 90 – 99 % of the adherent
The acute fish toxicity LC50 is about 5 – 50 ppm, 3,3 -dichlorobenzidine is removed [32].
depending on the type of fish and the diphenyl Wastes, such as production residues, con-
base. In terms of acute toxicity, diphenyl bases taminated disposable protective equipment, and
can be regarded as only slightly toxic to mam- empty packaging, which may contain diphenyl
mals. The oral LD50 for rats is 3820 mg/kg bases, are best incinerated. Suitable incinera-
for 3,3 -dichlorobenzidine, 404 mg/kg for o- tors must have a secondary incineration com-
tolidine, and 1920 mg/kg for o-dianisidine. partment in which a dwell time of at least 0.3 s
Benzidine achieves only a slight, and 3,3 - and a minimum temperature of 900 ◦ C are main-
dichlorobenzidine a moderate bioaccumulation tained [33].
in bluegill sunfish [27]. Thus benzidine is un-
likely reach a significant level in the food chain
[28]. 6. Characteristics of the
Because of the very low vapor pressures of
Diphenyl Bases
the diphenyl bases, emissions into the ambi-
ent air from production or processing works are
6.1. Benzidines
only possible in the form of dust. Such emis-
sions can certainly be prevented by filtering or Benzidine [92-87-5], 4,4 -biphenyl-diyldi-
by using wet separators. Diphenyl base concen- amine, C12 H12 N2 , M r 184.24, mp (coarse rods)
trations in the ambient air are monitored using 128 ◦ C, crystallizes out of the melt usually in a
TLC or HPLC [29]. metastable modification with a melting point of
In aqueous solution 3,3 -dichlorobenzidine 122 – 125 ◦ C, bp 400 – 401 ◦ C at 98.7 kPa.
base is very quickly degraded by photolysis,
with monochlorobenzidine and benzidine be-
ing formed as intermediates [30], [31]. 3,3 -
Dichlorobenzidine, o-tolidine, and o-dianisidine
8 Benzidine and Benzidine Derivatives
Benzidine crystallizes out of water above water and in alcohol. The dihydrochloride hy-
80 ◦ C in the anhydrous form; below 60 ◦ C, it re- drolyzes to form the monohydrochloride and hy-
tains one molecule of water of crystallization; drochloric acid.
the monohydrate melts at 104 – 105 ◦ C. Pure Benzidine sulfate [531-86-2], C12 H12 N2
benzidine is colorless. One part by weight of · H2 SO4 , forms microscopic flakes and is virtu-
benzidine dissolves in 2447 parts of water at ally insoluble in water and alcohol. Because of
12 ◦ C, in 106.5 parts of water at 100 ◦ C, and its poor solubility, benzidine sulfate can be used
in 45 parts of ether or 13 parts of absolute ethyl for the quantitative determination of sulfuric
alcohol at 20 ◦ C. Benzidine is diacidic; at 30 ◦ C, acid. Benzidine disulfate, C12 H12 N2 · 2 H2 SO4 ,
K1 = 9.3×10−10 and K2 = 5.6×10−11 . The heat is formed from benzidine sulfate and sulfuric
of neutralization is 106.5 kJ/mol. acid.
Benzidine slowly becomes discolored on ex- Benzidine has been produced from nitro-
posure to air. It is chemically resistant to water. benzene on an industrial scale since about
Blue, green, or red colorations and precipitates, 1880. Commercial production methods include
many of which are based on quinonoid struc- alkaline iron reduction [14], amalgam reduction,
tures, form depending on the nature of the ox- and electrochemical reduction. The resultant hy-
idizing agent and the reaction conditions used. drazobenzene is rearranged with hydrochloric
These color reactions can be used to detect nu- acid or sulfuric acid during cooling. The base
merous oxidizing agents. is then isolated in the form of benzidine hydro-
When chlorine is passed into a sus- chloride or benzidine sulfate. The conversion of
pension of benzidine hydrochloride in these salts to the free base is avoided as much
concentrated hydrochloric acid, 3,3 ,5,5 - as possible because of the chronic toxicity of
tetrachlorobenzidine [41687-08-5] is formed. benzidine.
Bromine forms the corresponding tetrabro- An aqueous benzidine solution gives a blue
mobenzidine [62477-23-0]. 2-Nitrobenzidine coloration in the presence of aqueous potassium
[2243-78-9], 2,2 -dinitrobenzidine, and a lit- ferricyanide. The sensitivity is about 10 mg/kg.
tle 2,3 -dinitrobenzene are formed from benzi- In very dilute colorless bromine water, benzi-
dine sulfate in concentrated sulfuric acid upon dine yields a blue coloration. The solution turns
the addition of potassium nitrate [34]. Sulfonic green when more reagent is added and finally
acids or sulfones of benzidine are formed un- becomes colorless again upon the precipitation
der sulfonating conditions. The N-acetylation of reddish flakes. Quantitative determination is
products, which also occur as metabolites in by titration with 0.1 N sodium nitrite solution in
animal digestion, are formed with acetic anhy- hydrochloric acid, using potassium iodide and
dride. They are N-acetyl-benzidine [3366−61- starch paper as the indicator. Quantitative de-
8], C14 H14 N2 O, and N,N -diacetylbenzidine termination of benzidine in dyestuffs involves
[613−35−4], C16 H16 N2 O2 . petroleum ether extraction, column chromato-
The most important commercial reaction is graphic separation, and colorimetric determina-
the diazotization of the two amino groups. Re- tion [35]. Benzidine can be detected in urine or
action with nitrous acid converts benzidine into air by extraction with m-cresol methyl ether and
the tetrazonium compound [13], in which the reaction with potassium 1,2-naphthoquinone-
first diazonium group is coupled very vigorously 4-sulfonate [5908-27-0]; the detection limit is
whereas the second reacts more slowly. As a re- 0.33 mg/kg [36], [37]. A simple and rapid
sult it is possible to produce asymmetrical di- method for the detection of benzidine in the
azo dyes. Gradual diazotization is also possible urine is based on its the color-forming reaction
(→ Azo Dyes). with cyanogen bromide; the detection limit is
In the presence of acids, benzidine forms salts 0.05 mg/kg [38]. Benzidine in the urine can be
that are difficult to dissolve. Among these are separated from its metabolites by means of paper
benzidine monohydrochloride [14414−68−7], chromatography [39].
C12 H12 N2 · HCl, needles, sparingly soluble Benzidine is used as the reagent base for the
in water, readily soluble in dilute hydrochlo- production of a large number of dyes, particu-
ric acid; benzidine dihydrochloride [531-85-1], larly azo dyes for wool, cotton, and leather. How-
C12 H12 N2 · 2 HCl, flakes, readily soluble in ever, because benzidine has been found to be car-
Benzidine and Benzidine Derivatives 9
3,3 -Dichlorobenzidine is made from o- 137 – 138 ◦ C. It forms colorless crystals, but
nitrochlorobenzene by reduction with zinc dust commercial products have a tinge of violet. It
and sodium hydroxide solution and subsequent is sparingly soluble in water but soluble in alco-
rearrangement with dilute hydrochloric acid or hol, ether, and benzene. One gram of ethyl ac-
sulfuric acid. It is assayed by titration with etate dissolves 0.285 g of o-dianisidine at 73 ◦ C.
sodium nitrite solution in dilute hydrochloric
acid and detected in human urine by colorime-
try using chloramine. The detection limit is
0.1 mg/kg [38].
Like o-tolidine, 3,3 -dichlorobenzidine is The pure compound is stable upon exposure
marketed as a free base and as the dihydro- to air, but commercial products turn violet. o-
chloride. Both are supplied as moist products Dianisidine is resistant to water but sensitive to
with water contents of 5 – 30 %. The so-called oxidizing agents.
urethane quality is taken to mean an anhydrous o-Dianisidine dihydrochloride [20325-40-0],
base, free of hydrochloric acid. C14 H16 N2 O2 · 2 HCl, forms prisms with mp
3,3 -Dichlorobenzidine was introduced 272 ◦ C (decomp.). It is readily soluble in hot
about 1932 and is now the most important water and sparingly soluble in cold water and
diphenyl base. It is used as the starting ma- alcohol.
terial for pigments with yellow and red shades. The hydrazo compound (2,2 -dimethoxy-
These are used for coloring printing inks, paints, hydrazobenzene [787-77-9]) is obtained by the
plastics, and rubbers. The important diarylide reduction of o-nitroanisole [91-23-6] with zinc
yellow pigments, which are incorrectly known dust and sodium hydroxide solution, often in a
as benzidine yellows, are formed by the combi- medium containing ethyl alcohol.
nation of 3,3 -dichlorobenzidine with acetic acid The reduction can also be performed elec-
arylides. 3,3 -Dichlorobenzidine is also used in trochemically or with a palladium catalyst in
the production of polyurethane rubbers. an aqueous solution of isopropyl alcohol and
sodium hydroxide. Rearrangement is carried out
2,2 ,5,5 -Tetrachlorobenzidine [15721- at a maximum of 20 ◦ C with 20 % sulfuric acid
02-5], 2,2 ,5,5 -tetrachloro-4,4 -biphenyl- [13], [14].
diyldiamine, C12 H8 Cl4 N2 , M r 322.02, mp Like benzidine and o-tolidine, o-dianisidine
134 – 137 ◦ C. forms colors with numerous oxidizing agents,
2,2 ,5,5 -Tetrachlorobenzidine is made by the e.g., copper, cobalt, and gold ions. o-Dianisidine
reduction of 2,5-dichloronitrobenzene with zinc is quantitatively determined by titration with ni-
dust and sodium hydroxide solution. The subse- trite using potassium iodide and starch paper as
quent rearrangement is carried out using sulfuric the indicator. o-Dianisidine can be detected in
acid or hydrochloric acid. The dihydrochloride the urine using potassium 1,2-naphthoquinone-
melts at 230 ◦ C. Tetrachlorobenzidine is mar- 4-sulfonate after extraction [47]. A rapid and
keted as the free base and is used to produce easy method is based on the color formed
yellow pigments. with cyanogen bromide. Its detection limit is
0.05 mg/kg [38].
The free o-dianisidine base and the dihydro-
chloride are marketed in moist forms with a
10 – 30 % water content.
o-Dianisidine is a starting material for the
production of disazo dyes and pigments.
6.4. Alkoxybenzidines o-Diphenetidine [6264-77-3], 3, 3 -dieth-
o-Dianisidine [119-90-4], 3,3 -dimethoxy- oxy- 4, 4 -biphenyl-diyldiamine, C16 H20 N2 O2 ,
4,4 - biphenyl-diyldiamine, C14 H16 N2 O2 , M r M r 272.35, mp 119 ◦ C, forms needles or flakes.
244.30, crystallizes dimorphically, rarely in nee- It assumes a grey or violet shade in commercial
dles, with mp 133 ◦ C, often in flakes with mp products. It is insoluble in cold water, slightly
12 Benzidine and Benzidine Derivatives
soluble in boiling water, and very soluble in al- crystallizes into needles which are converted
cohol, ether, and chloroform. into benzidine by decarboxylation at temper-
atures above 250 ◦ C. It is slightly soluble in
alcohol and ether.
Benzidine-2,2 -disulfonic acid is used in the containing sulfuric acid, and is decomposed by
production of yellow and red azo dyes. water.
Benzidinesulfone is produced by heating
Benzidine-3,3 -disulfonic acid [3365-90-0], benzidine sulfate with an excess of 20 – 40 %
4,4 -diaminobiphenyl-3,3 -disulfonic acid, oleum in a water bath.
C12 H12 N2 O6 S2 , M r 344.37, forms tetrahedral
flakes, virtually insoluble in alcohol and ether, Benzidinesulfone-disulfonic Acid, 3,7-
very slightly soluble in boiling water. diaminodibenzothiophene-2,8-disulfonic acid
5,5- dioxide, C12 H10 N2 O8 S3 , M r 406.41, crys-
tallizes in pale yellow needles, soluble in hot
water, slightly soluble in alcohol, virtually in-
soluble in cold hydrochloric acid and in dilute
Benzidine-3,3 -disulfonic acid is made by re- sulfuric acid.
acting one part of benzidine sulfate with two
parts of sulfuric acid monohydrate at 210 ◦ C.
8. Toxicology
8.1. Benzidine
The dihydrochloride, C12 H10 N2 O2 S · 2 HCl,
crystallizes as flakes from dilute hydrochloric The acute oral LD50 of benzidine adminis-
acid and is decomposed by water. The sulfate, tered to male rats is 1.57 g/kg [49]. Subacute
C12 H10 N2 O2 S · H2 SO4 · 1.5 H2 O, crystallizes dietary exposure of mice to concentrations of
as needles or flakes, is slightly soluble in water
14 Benzidine and Benzidine Derivatives
100 – 800 ppm resulted in cloudy swelling of the In summary, there is sufficient evidence that
liver, vacuolar degeneration of the renal tubules, benzidine is carcinogenic in mice, rats, and ham-
and hyperplasia of myeloid elements of the bone sters. Ample evidence exists that benzidine also
marrow and lymphoid cells in the thymus and is carcinogenic in humans.
spleen [50]. Little is known about the dermal The MAK commission has classified benzi-
or pulmonary absorption, but the toxic systemic dine in group A 1 (clearly carcinogenic). The
manifestations following these modes of expo- American Conference of Governmental Indus-
sure indicate that proportional amounts are ab- trial Hygienists (ACGIH) lists benzidine in
sorbed [51]. group A 1 b: “no exposure or contact by any
If benzidine is injected intravenously, its half- route – respiratory, skin, or oral, as detected by
life in blood exhibits several phases. The fourth the most sensitive methods – shall be permitted.”
and final phase has a half-life of 65 h in rats and
88 h in dogs [52]. The routes of elimination dif-
fered in the various animal species investigated. 8.2. 3,3 -Dichlorobenzidine
In rats, approximately 80 % of an i.v. dose was
excreted via feces. In dogs and monkeys 67 % The oral LD50 (rat) of 3,3 -dichlorobenzidine is
and in monkeys 50 % was eliminated via the 7.07 g/kg [81].
urine [52]. In chronic studies 100 mg was administered
Benzidine is metabolized to N-acetyl- orally to beagle dogs three times weekly for six
benzidine and N,N -diacetylbenzidine, which weeks and five times weekly thereafter for seven
is converted by an NADPH-dependent reac- years. Serum-glutamic-oxalacetic transaminase
tion to N-hydroxy-N,N -diacetylbenzidine and levels were increased [82], a sign of a slightly
3-hydroxy-N,N -diacetylbenzidine; the latter toxic effect upon the liver. Carcinoma of the
binds to nucleic acids [53]. bladder, hepatocellular carcinoma, and mam-
Benzidine is positive in the Ames test follow- mary gland tumors were also observed.
ing metabolic activation with liver homogenate 3,3 -Dichlorobenzidine is rapidly metabo-
from rats [54], [55] or humans [56]. The Ames lized. After an oral dose of one gram, dogs
test is also positive for the urine of rats that excrete only 2 % unchanged in the feces and
have been exposed to benzidine by oral ad- urine [83]. Rats and dogs treated with 3,3 -
ministration [57]. N-Acetylbenzidine [57] and dichlorobenzidine showed multiphasic blood
N-hydroxy-N,N -diacetylbenzidine [53] also in- clearances. The half-life of the final phase was
duce point mutations in the Ames system. Ben- 68 h in rats and 86 h in dogs. The majority of
zidine induces unscheduled DNA synthesis in the administered dose was recovered from the
HeLa cells [58] and in rat hepatocytes [59]. After bile, thereby demonstrating the importance of
metabolic activation, DNA strand breaks [60], the hepato-biliary excretion [52].
[61] and cell transformation [62], [63] occur in In the Ames test, 3,3 -dichlorobenzidine was
V-79 cells. positive with and without adding a metabolic ac-
Benzidine hydrochloride produces hepato- tivation system [55], [84], [85]. Positive results
cellular carcinoma in mice at a dose level of were also obtained in the unscheduled DNA syn-
150 mg/kg [64–67]. Evidence of the carcino- thesis test in HeLa cells [58] and in the cell trans-
genic properties of benzidine has been found in formation assay in baby hamster kidney cells
rats [68] and hamsters [69]. [86].
The first information about the carcinogenic When mice were treated with 3,3 -
properties of benzidine in humans was published dichlorobenzidine in a dietary concentration
by Oppenheimer in 1927 [70]. He observed of 1000 ppm for one year, all of the animals de-
tumors of the bladder among workers in the veloped hepatomas [87]. In another experiment,
dyestuffs industry. This observation has been rats developed tumors in various organs after an
confirmed by many other researchers [71–80]. exposure for one year followed by an unlimited
The incidence of bladder cancer in workers de- observation period [88]. The results are diffi-
creased after reduction of the industrial exposure cult to evaluate because of the absence of an
[80]. adequate control group. When rats were treated
with 1000 ppm of 3,3 -dichlorobenzidine in the
Benzidine and Benzidine Derivatives 15
diet, significant statistical increases were found In the presence of rat liver homogenate, o-
for granulocytic leukemias, mammary adeno- dianisidine is positive in the Ames test [85]. It is
carcinomas, and zymbal gland carcinomas [89]. capable of inducing unscheduled DNA synthesis
Hamsters did not develop tumors at the same in HeLa cells [58] and in primary rat hepatocytes
dose level, but following doses of 3000 ppm, tu- [98], and it provokes cell transformation in baby
mors of the bladder and the liver were observed hamster kidney cells in vitro [86]. o-Dianisidine
[69], [90]. is carcinogenic in rats. An oral dose of 30 mg ad-
In epidemiological studies of workers ex- ministered three times per week for 13 months
posed to 3,3 -dichlorobenzidine, no bladder tu- produced tumors in the zymbal glands [98], [99]
mors were found [81], [91], [92]. In summary, and in other tissues [100], [101].
3,3 -dichlorobenzidine is carcinogenic in labo- No conclusive epidemiological studies have
ratory animals, but proof of its oncogenic prop- been reported on the carcinogenicity of o-
erties in humans does not exist. Both commis- dianisidine in humans. No MAK value has been
sions (MAK and ACGIH) have classified this established. o-Dianisidine is classified in group
compound in category 2, respectively, group III B.
A II. Neither MAK nor TLV values have been
established. 3,3 -Dichlorobenzidine is absorbed
by the skin. 9. References
General References
8.3. o-Tolidine (3,3 -Dimethylbenzidine) 1. Beilstein, 13, 214, 227, 234, 255, 256, 340,
807, 808; 14, 567, 568, 770, 794, 795, 796; 18,
591, 636; 13 (1), 58, 66, 67, 79, 331, 332; 14
o-Tolidine can enter the body by percutaneous
(1), 647, 737, 743; 18 (1), 590; 13 (2), 90, 102,
absorption, ingestion, or inhalation [93]. It is 106, 116, 152, 502, 504; 14 (2), 344, 345, 479;
metabolized in exposed workers to diacetyl- 18 (2), 490; 13 (3), 425, 437, 447, 484, 2310;
o-tolidine and to a hydroxyamino metabolite 14 (3), 2264, 2265; 18 (3/4), 7289, 8286.
(probably 5-hydroxy-o-tolidine), which are ex- 2. Houben-Weyl, vol. X/2, pp. 693 – 743;
creted via the urine [94]. Dogs are unable to vol. XI/1, pp. 839 – 848.
acetylate aromatic amines such as o-tolidine 3. T. S. Scott: Carcinogenic and Chronic Toxic
[95]. Hazards of Aromatic Amines, Elsevier,
In the Ames test, o-tolidine is a weak mu- Amsterdam – New York 1962.
tagen [85], [96]. o-Tolidine acts as a systemic 4. R. Powell, M. Murray, C. Chen, A. Lee:
carcinogen in Sherman rats when administered Survey of the manufacture, import and uses for
subcutaneously at a dose level of 60 mg per rat benzidine, related substances and related dyes
per week. It induces mainly tumors of the zym- and pigments, Report 1979
bal glands [97]. No carcinogenic potential could EPA/560/13 – 79/005; Order No.
be observed in hamsters after feeding them a diet PB-296544. Avail. NTIS. Gov. Rep.
containing 1000 ppm of o-tolidine [69], [90]. No Announce. Index (U.S.), 79 (1979) no. 20, 120;
Chem. Abstr. 92 (1980) 7831 e.
epidemiological studies in humans are available.
5. T. J. Haley: “ Review of the literature and
Exposure limits have been established. The problems associated with the use of benzidine
MAK value is 5 mg/kg (22 mg/m3 , group III B), and its congeners,” Clin. Toxicol. 8 (1975)
and the TLV is 2 mg/kg (9 mg/m3 , group A 2). no. 1, 13 – 42 (106 refs.).
6. W. Seidenfaden: Künstliche organische
Farbstoffe und ihre Anwendungen, Enke
8.4. o-Dianisidine Verlag, Stuttgart 1957.
(3,3 -Dimethoxybenzidine) 7. K. Venkataraman: The Chemistry of Synthetic
Dyes, vol. I. (1952); vol. III (1970); vol. V
Information about the biotransformation of o- (1971), Academic Press, New York – London.
8. W. Herbst, K. Hunger: “Azo-Pigmente,
dianisidine is rather limited. In dogs, 3,3 - dihy-
Eigenschaften, Anforderungen,
droxybenzidine is formed as a major metabolite
Entwicklungstendenzen,” Progr. Org. Coat. 6
[83]. (1978) 105 – 210.
16 Benzidine and Benzidine Derivatives
9. Ullmann, 4th ed., vol. 18, pp. 661 – 695. p. 144; Berufsgenossenschaft der chemischen
Industrie, Unfallverhütungsvorschrift Nr. 47;
Specific References Schutzmaßnahmen bei Umgang mit
10. W. A. Rye, P. F. Woolrich, R. P. Zanes: “Facts krebserzeugenden Arbeitsstoffen vom
and Myths Concerning Aromatic Diamine 1. 10. 1982.
Curing Agents,” JOM J. Occup. Med. 12 22. Zwölfte Verordnung zur Durchführung des
(1970) no. 6, 211 – 215. Bundes-Immissionsschutzgesetzes –
11. R. Merten: “Die Synthese heterocyclischer Störfall-Verordnung – vom
Ringsysteme für wärmebeständige Kunststoffe 27. 6. 1980. Bundesgesetzblatt 1980, part I,
aus Polyisocyanaten,” Angew. Chem. 83 p. 772.
(1971) 339 – 347; Angew. Chem. Int. Ed. Engl. 23. Hauptverband der gewerblichen
10 (1974) 294. Berufsgenossenschaften, Spezifische
12. A. Horvath, B. Vollmert: “Über den Einfluß Einwirkungsdefinitionen, ZH 1/600.16,
von Triäthylamin auf die Viskosität von proposal of 10.1979, Carl Heymanns Verlag,
Polyamidcarbonsäuren aus Köln.
Pyromellitsäuredianhydrid und Benzidin in 24. Arrêté Royal du 3. 10. 1973, Moniteur Belge
Dimethylacetamid,” Angew. Chem. 83 (1971) 23. Nov. 1973.
375; Angew. Chem. Int. Ed. Engl. 10 (1971) 25. Labour Safety and Hygienic laws 2. 6. 1972.
348. 26. R. Montesano, L. Tomatis: “Legislation
13. H. E. Fierz-David, L. Blangey: Grundlegende Concerning Chemical Carcinogens in Several
Operationen der Farbenchemie, 8th ed., Industrialized Countries,” Cancer Res. 37
Springer Verlag, Wien 1982. (1977) 310 – 315.
14. P. H. Groggins: Unit Processes in Organic 27. H. T. Appleton, H. C. Sikka: “Accumulation,
Synthesis, 5th ed., McGraw-Hill, New Elimination and Metabolism of
York – Toronto – London 1958. Dichlorobenzidine in the Bluegill Sunfish,”
15. Houben-Weyl, vol. IV/2, p. 494. Environ. Sci. Technol. 14 (1980) no. 1, 50 – 54.
16. D. V. Banthorpe et al., J. Chem. Soc. Perkin 28. P. Y. Lu, R. L. Metcalf, N. Pummer, D.
Trans. 2 1973, 551 – 56. H. J. Shine et al., J. Mandel: “The environmental fate of three
Am. Chem. Soc. 99 (1977) 3719 – 23. Z. J. carcinogens,” Arch. Environ. Contam. Toxicol.
Allan, Justus Liebigs Ann. Chem. 1978, no. 5, 6 (1977) no. 2 – 3, 129 – 42; Chem. Abstr. 88
705 – 09. (1978) 27196.
17. International Labour Office: “Occupational 29. R. Morales, S. M. Rappaport, R. E. Hermes:
Safety and Health Series No. 39,” “Air sampling and analytical procedures for
Occupational Cancer-Prevention and Control, benzidine, 3,3 -dichlorobenzidine and their
Geneva 1977. M. R. Zavon, U. Hoegg, E. salts,” Am. Ind. Hyg. Assoc. J. 40 (1979) 970.
Bingham: “Benzidine exposure as a cause of 30. H. C. Sikka, H. T. Appleton, S. Banerjee; Fate
bladder tumors,” Arch. Environ. Health 27 of 3,3 -Dichlorobenzidine in Aquatic
(1973) no. 1, 1 – 7. Environments, U.S.-E.P.A.-600/3-78-068,
18. IARC Monogr. 29 (1982) 149 – 181
National Technical Information Service,
(Benzidine and its Sulfate, Hydrochloride and
Springfield, Virginia 22161, USA, 1978.
Dihydrochloride); 239 – 256
31. S. Banerjee, H. C. Sikka, R. Gray, C. M. Kelly:
(3,3 -Dichlorobenzidine and its
“Photodegradation of 3,3 -Dichlorobenzidine,”
Dihydrochloride).
Environ. Sci. Technol. 12 (1978) no. 13,
19. Department of Labor. Occupational Safety and
1425 – 27.
Health Administration: Carcinogens,
32. R. J. Hackman, T. Rust: “Removal and
Occupational Health and Safety Standards,
decontamination of residual
Federal Register, vol. 39, no. 20, Part III,
3,3 -Dichlorobenzidine,” Am. Ind. Hyg. Assoc.
Washington, D. C., 1974, pp. 3757,
J. 42 (1981) 341 – 47.
3771 – 3773.
33. Erste Allgemeine Verwaltungsvorschrift zum
20. Statutory Instruments 1967, no. 879: Factories.
Bundes-Immissionsschutzgesetz (Technische
The Carcinogenic Substances Regulations
Anleitung zur Reinhaltung der Luft) vom
1967. Publ. by Her Majesty’s Stationery Office
28. 8. 1974. Gemeinsames Ministerialblatt
1967.
21. Verordnung über gefährliche Arbeitstoffe vom Ausgabe A, 25, 4. 9. 1974, p. 442.
11. 2. 1982, Bundesgesetzblatt 1982, part I, 34. Ullmann, 4th ed., vol. 8, p. 359.
Benzidine and Benzidine Derivatives 17
35. F. Jones, D. Patterson, D. Srinivasan: “The 55. D. Anderson, J. A. Styles, Br. J. Cancer 37
determination of free benzidine in dyes,” J. (1978) 924 – 930.
Soc. Dyers Color. 96 (1980) no. 12, 628 – 31. 56. S. Haworth, T. Lawlor, in: 9th Annual Meeting
36. P. Engelbertz, E. Babel: “Nachweis von of the Environmental Mutation Society, San
Benzidin und seinen Umwandlungsprodukten Francisco 1978, Abstract No. 1 a – 8.
im Harn und in Organteilen,” Zentralbl. 57. K. J. Tanaka, S. Marui, T. Mii, Mutat. Res. 79
Arbeitsmed. Arbeitsschutz 3 (1953) 161 – 68. (1980) 173 – 176.
P. Engelbertz, E. Babel: “Über die Anwendung 58. C. N. Martin, A. C. McDermid, R. C. Garner,
der Benzidin-Testmethode mit Cancer Res. 38 (1978) 2621 – 2627.
1,2-naphthochinon-4-sulfonsaurem Kalium 59. G. M. Williams, Cancer Let. 4 (1978) 69 – 75.
zur Bestimmung der gesundheitlichen 60. J. A. Swenberg, G. L. Petzold, P. R. Harbach,
Gefährdung in Benzidinbetrieben,” Zentralbl. Biochem. Biophys. Res. Commun. 72 (1976)
Arbeitsmed. Arbeitsschutz 4 (1954) 40 – 42. 732 – 738.
37. P. Engelbertz, E. Babel: “Nachweis und 61. G. L. Petzold, J. A. Swenberg, Cancer Res. 38
Bestimmung von 3,3 -Dichlorbenzidin und (1978) 1589 – 1594.
3-Oxybenzidin,” Zentralbl. Arbeitsmed. 62. J. Ashby, J. A. Styles, D. Paton, Br. J. Cancer
Arbeitsschutz 6 (1956) 58 – 60. 38 (1978) 34 – 50.
38. O. Winkler: “Beitrag zum Nachweis von Di- 63. R. J. Pienta, in F. J. de Serres, E. Hollaender
phenylbasen im Harn,” Zentralbl. Arbeitsmed. (eds.): Chemical Mutagens. Principles and
Arbeitsschutz 9 (1959) 140 – 42. Methods for their Detection, vol. 6, Plenum,
39. S. Laham, J. P. Farant, M. Potvin, Ind. Med. New York 1980, pp. 175 – 202.
Surg. 39 (1970) 142 – 47. 64. S. D. Vesselinovitch, K. V. N. Rao, N.
40. H. Steinberg: “The hazard of benzidine to Mihailovich, Cancer Res. 35 (1975)
criminal justice personnel,” NBS Spec. Publ. 2814 – 2819.
U.S. 1977, 480 – 421; Chem. Abstr. 87 (1977) 65. S. D. Vesselinovitch, K. V. N. Rao, N.
178486. Mihailovich, Natl. Cancer Inst. Monogr. 51
41. W. Zönnchen, DD 31935, 1963. (1979) 239 – 250.
42. Bayer, DE 2232095, 1972. 66. C. H. Frith, K. P. Baetcke, C. J. Nelson, G.
43. Celanese Corp., US 3865876, 1969. Schieferstein, Toxicol. Lett. 4 (1979)
44. Celanese Corp., US 3943175, 1969. 507 – 518.
45. D. R. Coffin, G. A. Serad, H. L. Hikcs, R. T. 67. C. H. Frith, K. P. Baetke, C. J. Nelson, G.
Montgomery: “Properties and Applications of Schieferstein, Eur. J. Cancer 16 (1980)
Celanese PBI-Polybenzimidazole Fiber,” Text. 1205 – 1216.
Res. J. 52 (1982) no. 7, 466 – 72. 68. E. Boyland, J. Harris, E. S. Horning, Br. J.
46. Borma BV, DE 3020846, 1979. Cancer 8 (1954) 647 – 654.
47. P. Engelbertz, E. Babel: “Nachweis von 69. U. Saffiotti, F. Cefis, R. Montesano, A. R.
o-Tolidin und o-Dianisidin sowie ihrer Sellakumar, in W. B. Deichmann, K. F. Lampe
Umwandlungsprodukte im Harn und in (eds.): Bladder Cancer: A Symposium,
Organteilen,” Zentralbl. Arbeitsmed. Birmingham, Aesculapius Publ. Co.,
Arbeitsschutz 4 (1954) 179 – 83. Birmingham 1967, pp. 129 – 135.
48. Clayton Aniline Co., EP 32784, 1980. 70. R. Oppenheimer, Z. Urol. Chir. (Gynaekol.)
49. J. Marhold, M. Matrka, M. Hub, F. Ruffer, 21 (1927) 336 – 350.
Neoplasma 15 (1968) 3 – 10. 71. A. Muller, Z. Urol. Chir. (Gynaekol.) 36
50. K. V. N. Rao, J. H. Rust, N. Mihailovich, S. D. (1933) 202 – 219.
Vesselinovitch, J. M. Rice, Fed. Proc. Fed. Am. 72. G. Di Maio, Arch. Ital. Urol. 14 (1937)
Soc. Exp. Biol. 30 (1971) 444. 283 – 385.
51. G. Ghetti, Med. Lav. 51 (1960) 102 – 114. 73. M. W. Goldblatt, Br. J. Ind. Med. 6 (1949)
52. H.-M. Kellner, O. E. Christ, K. Lötzsch, Arch. 65 – 81.
Toxicol. 31 (1973) 61 – 79. 74. M. Barsotti, E. C. Vigliani, Med. Lav. 40
53. K. C. Morton, F. A. Belland, F. E. Felland, (1949) 129 – 138.
N. F. Fulland, F. F. Kandlubarr, Cancer Res. 75. T. S. Scott, Br. J. Ind. Med. 9 (1952) 127 – 132.
40 (1980) 751 – 757. 76. P. Aboulker, G. Smagghe, Arch. Mal. Prof. 14
54. B. N. Ames, W. E. Durston, E. Yamasaki, F. D. (1953) 380 – 386.
Lee, Proc. Natl. Acad. Sci. U.S.A. 70 (1973) 77. F. Uebelin, A. Pletscher, Schweiz. Med.
2281 – 2285. Wochenschr. 84 (1954) 917 – 920.
18 Benzidine and Benzidine Derivatives
78. M. Douilett, J. Bourret, A. Convert, Arch. Mal. 91. T. Gadian, Chem. Ind. 1975, 4th Oct.,
Prof. 20 (1959) 713 – 733. 821 – 831.
79. J. L. Billard-Duchesne, Acta Unio Int. 92. I. McIntyre, J. Occup. Med. 17 (1975) 23 – 26.
Cancrum 16 (1960) 284 – 288. 93. J. W. Meigs, L. J. Sciarini, W. A. Van Sandt,
80. K. M. Ferber, W. J. Hill, D. A. Cobb, Am. Ind. Arch. Ind. Hyg. 9 (1954) 122.
Hyg. Assoc. J. 37 (1976) 61 – 68. 94. H. M. L. Dieteren, Arch. Environ. Health 12
81. H. W. Gerarde, D. F. Gerarde, J. Occup. Med. (1966) 30.
16 (1974) 322 – 344. 95. IARC, Monographs on the evaluation of
82. E. F. Stula, H. Sherman, W. R. Clayton, carcinogenic risk of chemicals to man, vol. I,
Toxicol. Appl. Pharmacol. 31 (1975) International Agency for Research on Cancer,
159 – 176. Lyon 1972, pp. 88 – 91.
83. L. J. Sciarmy, J. W. Meigs, Arch. Environ. 96. J. I. Ferretti, W. Lu, M. B. Liu, Am. J. Clin.
Health 2 (1961) 584 – 588. Pathol. 67 (1977) 526 – 527.
84. R. C. Garner, A. L. Walpole, F. L. Rose,
97. G. B. Pliss, M. A. Zabezhinsky, J. Natl. Cancer
Cancer Lett. 1 (1975) 39 – 42.
Inst. 45 (1970) 283.
85. E. J. Lazear, S. C. Louie, Cancer Lett. 4
98. G. B. Pliss, Gig. Tr. Prof. Zabol. 9 (1965) 18.
(1977) 21 – 25.
99. G. B. Pliss, Acta Unio Int. Cancer 19 (1963)
86. I. A. Styles, Br. J. Cancer 37 (1978) 931 – 936.
87. H. Osanai, J. Sci. Labour 52 (1976) 179 – 201. 499.
88. G. B. Pliss, Vopr. Onkol. 5 (1959) 524 – 533. 100. ACGIH, Documentation of the Threshold
89. E. F. Stula, J. R. Barnes, H. Sherman, C. F. Limit Values, 3rd ed., American Conference of
Reinhardt, J. A. Zapp, J. Environ. Pathol. Governmental Industrial Hygienists,
Toxicol. 1 (1978) 475 – 490. Cincinatti, Ohio, 1971.
90. A. R. Sellakumar, R. Montesano, U. Saffiotti, 101. Z. Hadidian, T. N. Fredrickson, E. K.
Proc. Am. Assoc. Cancer Res. 10 (1969) Weisburger, J. H. Weisburger, R. M. Glass, N.
Abstr. 309. Mantel, J. Natl. Cancer Inst. 41 (1968) 985.